Cargando…
Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
Although amyloid-β (Aβ) peptide accumulation is considered as a key early event in the pathogenesis of Alzheimer’s disease (AD), the precise pathophysiology of this deadly illness remains unclear and no effective remedies capable of inhibiting disease progression have been discovered. In addition to...
Autores principales: | Liu, Ping, Wang, Yunyun, Sun, Yan, Peng, Guoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064449/ https://www.ncbi.nlm.nih.gov/pubmed/35520949 http://dx.doi.org/10.2147/CIA.S357558 |
Ejemplares similares
-
Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
por: Sung, Pi-Shan, et al.
Publicado: (2020) -
Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
por: Wang, Qinqin, et al.
Publicado: (2015) -
Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2016) -
Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
por: Fernando, Kurukulasooriya Kavindya Madushani, et al.
Publicado: (2021) -
Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
por: Das, Bhaskar C., et al.
Publicado: (2019)